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Abstract
Few data are available regarding the reliability of fluorescence in-situ hybridization (FISH), especially for chromosomal
deletions, in high-throughput settings using tissue microarrays (TMAs). We performed a comprehensive FISH study for the
detection of chromosomal translocations and deletions in formalin-fixed and paraffin-embedded (FFPE) tumor specimens
arranged in TMA format. We analyzed 46 B-cell lymphoma (B-NHL) specimens with known karyotypes for translocations of
IGH-, BCL2-, BCL6- and MYC-genes. Locus-specific DNA probes were used for the detection of deletions in chromosome
bands 6q21 and 9p21 in 62 follicular lymphomas (FL) and six malignant mesothelioma (MM) samples, respectively. To test
for aberrant signals generated by truncation of nuclei following sectioning of FFPE tissue samples, cell line dilutions with
9p21-deletions were embedded into paraffin blocks. The overall TMA hybridization efficiency was 94%. FISH results
regarding translocations matched karyotyping data in 93%. As for chromosomal deletions, sectioning artefacts occurred in
17% to 25% of cells, suggesting that the proportion of cells showing deletions should exceed 25% to be reliably detectable.
In conclusion, FISH represents a robust tool for the detection of structural as well as numerical aberrations in FFPE tissue
samples in a TMA-based high-throughput setting, when rigorous cut-off values and appropriate controls are maintained,
and, of note, was superior to quantitative PCR approaches.
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Introduction
A variety of methods are available for the detection of genetic
aberrations in the routine diagnostic work-up of tumor specimens.
Of those, classical chromosome banding and fluorescence in-situ
hybridization (FISH) are of major importance. Although conven-
tional cytogenetic approaches are still considered to be the gold
standard in genetic diagnostics, allowing for the comprehensive
analysis of tumor-specific alterations in the karyotype, banding
analyses are limited by the availability of fresh material and by the
need for in-vitro cultivation of tumor cells. In contrast, FISH
analyses are not restricted to metaphase spreads prepared from
freshly isolated dividing tumor cells, but can be performed on
formalin-fixed paraffin-embedded (FFPE) interphase nuclei.
Moreover, FISH can detect sub-clonal genetic changes, that
may be missed by chromosome banding, therefore offering
superior sensitivity in comparison with conventional cytogenetic
approaches [1]. Of importance, a major advantage of FISH assays
is the possibility to perform hybridizations in high-throughput
approaches using tissue microarrays (TMA) in diagnostic settings,
and especially for retrospective studies of archival pathological
specimens. FISH on TMAs facilitate an expeditious analysis of
specific genetic alterations in up to hundred tumor samples on a
single slide, therefore enormously reducing costs and execution
time, while keeping the experimental procedure constant [2]. A
number of these high-throughput studies have been performed on
tumor specimens and it is generally agreed that translocations and
gene amplifications can be readily detected in FFPE TMA formats
[3–5]. A meticulous analysis of the reliability of the results of
translocation analyses on TMAs, however, has not been convinc-
ingly done so far, and it is still a matter of debate whether deletions
can be reliably detected using the TMA approach.
In order to address these open questions, we investigated a
panel of B-cell lymphoma (B-NHL) and malignant mesothelioma
samples. Since two main settings have to be considered in the
analysis of the reliability of FISH, rearrangement and copy
number evaluation studies, especially the detection of deletions, we
employed
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(1) a panel of FISH break-apart probes, detecting the hallmark
lymphoma-associated translocations of the IGH-, BCL2-,
BCL6- and MYC-loci in 46 B-NHL samples, respectively,
the genetic aberrations of which had previously been
determined by classical banding analysis and that served as
internal control using the gold standard.
(2) locus-specific DNA-probes in order to detect numerical
aberrations, especially deletions, on FFPE TMA tumors of
62 B-NHL and six malignant mesothelioma samples.
Also pertaining to the latter point, we compared TMA-FISH to
the hybridization of whole tissue sections, as well as to a
quantitative real-time PCR (qPCR) approach targeting several
genetic loci.
Results
Translocations of BCL2, BCL6, MYC and IGH can be reliably
detected by FISH on TMAs
A total of 46 B-NHL tumor samples with available chromosome
banding data had been spotted on TMAs. Following initial testing
as described in the Materials and Methods section, all 46 tumor
samples spotted on TMAs were hybridized with the four break-
apart probes, thus performing a total of 184 hybridizations. A low
hybridization quality without evaluable signals or loss of TMA
scores following pretreatment was observed in 13/184 hybridiza-
tions (7%) (Table S1), and these cases were excluded from further
analysis.
Taking into account only the chromosomal bands harboring
BCL2-, BCL6-, IGH- and MYC loci, translocations had been
detected in 32/46 tumor samples by chromosome banding, while
FISH analysis revealed breaks in 30/46 samples (Table 1, Table
S1). The mean frequency of cells with signal constellations
indicative of a translocation was 53% (range: 37–86%), 45%
(range: 19–80%), 54% (range: 19–95%) and 34% (range: 24–
50%), for BCL2, BCL6, IGH and MYC, respectively. There were
no significant differences in the frequency of cells showing breaks,
when different lymphoma entities were separately analyzed.
Similar numbers of cells showing translocation signals were seen
in 51 B-NHL samples that were investigated by FISH on whole
tissue sections in a routine diagnostic setting at the Department of
Clinical Pathology, Robert-Bosch-Hospital, Stuttgart (data not
shown). In this unrelated series, lymphomas with BCL2 or MYC
translocations showed a minimum of 32% and 25% cells with
signals indicative for rearrangements, respectively. Since the
number of cells showing translocation signals reached 94% in
MYC-positive samples, the mean frequency of cells with breaks in
MYC rearranged samples was higher (67%, range: 25% to 94%)
than the frequency of positive cells in BCL2-rearranged cases
(53%, range: 32% to 75%). Not unexpectedly, the MYC-positive
sample with a low translocation frequency of 25% cells with breaks
was a (‘‘double-hit’’) FL, while the remaining samples with 40% to
94% positive cells were all DLBCL and Burkitt lymphomas (BL),
obviously reflecting different numbers of non-tumorous bystander
cells in the respective entities.
Translocations involving BCL2 on chromosome 18q21 were
observed in five lymphomas by chromosome banding, one of them
with an unbalanced translocation without identifiable partner.
FISH analysis with the BCL2 break-apart probe disclosed breaks at
18q21 in all these cases and, additionally, in one tumor sample
without obvious translocation in the karyotype (Table S1). More
complex karyotypic alterations were observed for the BCL6 gene
locus in classical cytogenetics including inversions (n = 1), inser-
tions (n = 1), duplications (n = 2) and deletions (n = 2) affecting
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chromosomal band 3q27. While the samples with insertions and
duplications of 3q27 showed clear split signals using the BCL6
break-apart probe, the three deletions and inversions remained
undetected with FISH analysis. Translocations affecting 3q27
were revealed in six tumor samples by karyotyping (two of them
with unidentified translocation partners). In all cases, FISH on
TMAs disclosed these translocations. In addition, FISH revealed
chromosomal breaks involving the BCL6 gene in five B-NHL
patients without aberrant chromosome 3q27 region by banding
(Table S1). Translocations involving 8q24 harboring the MYC
gene locus were observed in three cases by karyotyping, and in all
tumors a MYC-break was evident also upon hybridization with the
MYC break-apart probe. Moreover, one more B-NHL sample was
found to be translocation-positive in the FISH approach, while this
translocation remained undetected by chromosome banding
(Table S1). Translocations affecting 14q32, involving the IGH
locus, were observed in 18 B-NHL on the karyotypic level. FISH
results demonstrated corresponding results for IGH-breaks in all
samples. In addition, two more cases showed translocations of the
IGH-gene locus by FISH, but not by banding (Table S1). The
number of translocations detected for BCL2 and MYC, of note,
paralleled those encountered for IGH, thus indicating that the
main rearrangements of these oncogenes associated with the IGH
gene locus were covered with this approach (9/10, 90%).
However, some genetic aberrations occurred, especially involving
the BCL6 gene (9/17, 53%), that were not associated with a
juxtaposition to the IGH gene locus, reflecting the aforementioned
deletions, duplications, insertions and inversions that affected
BCL6.
In conclusion, a total of 171/184 hybridizations (93%) yielded
adequate hybridization quality, enabling the accurate FISH-based
evaluation of translocation signals (Table 1, Table S1). There were
only slight differences in the evaluation of the cases by the two
independent observers. Specifically, 8/171 hybridizations (5%), in
which the number of cells with break-apart signals were close to
the cut-off ratio determined, were evaluated positive by observer 1
and negative by observer 2. Re-hybridization of these samples in
whole tissue sections then resulted in concordant evaluation by the
two observers (all evaluated as negative). Comparing results
obtained by chromosome banding and FISH, concordant findings
were observed in 159/171 calls (93%) (Table S1). The number of
cases with genetic alterations detected solely by FISH was 9/171
(5%). To avoid the generation of false-positive results obtained by
FISH on TMA format, these discrepant samples were subse-
quently re-hybridized on whole tissue sections. In 7/9 tissue
samples the results initially obtained by TMA-FISH could be
validated also on whole tissue sections, while the remaining two
specimens failed to yield analyzable results in that format (Table 1,
Table S1). In 3/171 cases (2%), aberrations (deletions and
inversions of BCL6) were observed only by classical cytogenetics.
In addition, FISH analysis was repeated in 25 of 46 samples
initially studied on TMAs using whole tissue sections by re-
hybridizing them with break-apart probes for BCL2, BCL6, MYC
and IGH. Of these 100 hybridization events, 12 (12%) were not
evaluable on the TMAs due to inadequate pepsin digestion or loss
of tissue scores following pretreatment. All 88 evaluable hybrid-
izations (hybridization efficiency: 88%) showed concordant results
in 100% on the TMA and the whole tissue sections (Table 1,
Table S1).
A tumor cell poulation exceeding 25% with deletions is
required to reliably detect genetic deletions in tissue
sections
To obtain insight into the accurate FISH-based detection of
genetic deletions in tissue sections, FFPE blocks were created from
MCL cell line suspensions with a defined tumor cell content.
Hybridization with the CDKN2A-specific probe resulted in the
detection of two signals in .70% nuclei in the cell block
containing pure JVM2 cells. In contrast, pure REC1 cells showed
homozygous deletion of the CDKN2A gene, while maintaining four
copies of the centromeric region (polyploid cells, DSMZ). In an
experimental setting, these cell lines were mixed at defined levels,
thus reducing the number of cells deleted for CDKN2 successively
(Figure 1A and C–D). The number of truncated cells created by
sectioning of the FFPE block, therefore, could be estimated: The
section artefact was defined as the difference between the total
number of cells with reduced CDKN2A signals and the expected
number of those nuclei. As shown in Figure 1A and C–D, the
number of section artefacts varied between 17% and 25%.
Therefore, equally taking into account the mathematical CDKN2A
cut-off ratio for deletion of 30%, as calculated from FISH analysis
of the negative controls, the number of CDKN2A-deleted cells
should exceed 30%, to reliably detect the genetic alteration
(Figure 1A).
Similar results were obtained using a qPCR approach. Wild
type CDKN2A with both copies maintained was observed in 100%
of JVM2 cells, while no gene copy was detected in REC1 cells.
With increasing numbers of REC1 cells in the REC1-JVM2
dilutions, a linear reduction of the CDKN2A-signal was obvious.
Reactive lymph node samples showed CDKN2A/HBB and
CDKN2A/TMEM2 ratios ranging from 0.63 to 1.06, thus defining
cut-off values for CDKN2A-deletions of 0.52 and 0.54, respectively
(Figure 1B). Similar to the FISH assay, a proportion of CDKN2A-
deleted cells higher than 25% was required for a reliable detection
of deletions (Figure 1B).
FISH analysis has a superior sensitivity in the detection of
numerical genetic alterations in FFPE tumor samples in
comparison with qPCR
To clarify whether FISH or qPCR is the more sensitive
approach for an adequate detection of selected deletion regions in
FFPE tissues, we used six malignant mesothelioma (MM) FFPE
samples, since MM have been shown to harbor CDKN2A-deletions
in 25–50% of cases [6,7]. In keeping with these data, two cases
turned out to harbor monoallelic CDKN2A deletions by FISH (in
36%–47% of cells), while in four of them a loss of both alleles was
disclosed (in 32–75% of cells). Using the qPCR approach in those
cases with HBB and MAL as internal controls, the deletions
detected by FISH could be validated in all four samples with loss of
both gene copies when referring to HBB, and in one of them when
referring to MAL. Monoallelic CDKN2A deletion was not
detectable by qPCR (Table 1, Table S1).
Ten (10/62) FL samples harboring deletions of 6q21 as detected
by chromosome banding analysis, as well as 51 of 62 FL samples
without cytogenetic data available were then investigated by FISH
and qPCR (Table 1, Table S1). One sample was not evaluable by
either method. Monoallelic deletion of ATG5 in 6q21 was verified
by FISH, both in TMA format and on whole tissue sections, using
locus-specific BAC clones in the ten samples with positive
cytogenetics (Table 1, Table S1). In these experiments, the mean
number of affected cells was 48% (range: 30% to 70%)
(Figures 2A–C). ATG5 deletions were also observed in 16/51
FL samples without cytogenetic data (50% of cells, range: 34 to
Robustness of FISH in a High-Throughput Format
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80%). In the 35 remaining samples, signal constellations indicative
of deletions were observed in numbers suggesting sectioning
artefacts (15%–28%). All 26 tumor samples with deletions of the
ATG5 locus as verified by FISH and the remaining 35 samples
with deletion signals below the cut-off level were then analyzed by
qPCR. Of the 26 cases with proven 6q deletion by FISH, only 13
samples (with 65% to 80% deletion-positive cells) showed an
ATG5 deletion by qPCR (Table 1, Table S1). Seven samples with
30% to 60% deletion-positive cells by FISH, showed ATG5/HBB
and ATG5/TMEM2 ratios slightly exceeding the cut-off level of
0.46 and 0.47 for ATG5/HBB and ATG5/TMEM2, respectively
(ranging from 0.49 to 0.64). In the six remaining cases exhibiting
clear-cut deletions by FISH, no constellation indicative of a gene
deletion (Figure 2C–D) was seen.
In addition, 20 FL samples from the initial test set of 46 B-NHL
without genomic aberrations of the 6q21-chromosomal region as
shown by chromosome banding were tested by FISH using DNA
probes directed against 6q21, and by PCR. None of the samples
investigated harbored deletions of the ATG5 gene by FISH neither
on TMA nor on whole tissue sections (showing only sectioning
artefacts with signal constellations indicative of deletions not
exceeding 29%). qPCR failed to reveal deletions as well (Table 1,
Table S1).
In conclusion, reliable results obtained by FISH analysis could
not be reproducibly validated by qPCR, either because of an
inadequate content of tumor cells showing deletions in the
specimens, or – in theory - due to underlying genetic aberrations
affecting the reference gene loci and thus the appropriate
evaluation of qPCR results in the tumor samples.
Discussion
Numerous studies have been conducted using DNA probes for
the detection of lymphoma-associated primary translocations. In
the majority of these studies, FISH turned out to be more sensitive
in comparison with conventional karyotyping [8]. Few data,
however, are available concerning the reliability of FISH in a
high-throughput setting using TMAs in solid tumors and
hematological malignancies [3–5]. In these studies, however, the
Figure 1. Experimental set up for the accurate testing of numerical genetic alterations in FFPE tumor tissue performing FISH (A) or
qPCR (B). Using JVM2 and REC1 MCL cell lines, cell dilutions containing different amounts of CDKN2A-deleted cells were established (ranging from
0% to 100% CDKN2A-deleted cells). Representative FISH results (C–D), indicating the occurrence of section artefacts in cell suspensions containing
only non-deleted CDKN2A (100% JVM2), by obtaining aberrant signal constellations not matching the expected signal distribution of two red and two
green copies (CDKN2A: marked in red; 9cen: marked in green, magnification: 1006). The cut-off level obtained from investigation of reactive lymph
node specimens is depicted as dashed line for the FISH (A) and the qPCR (B) analysis.
doi:10.1371/journal.pone.0095047.g001
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technical feasibility and the robustness of the TMA hybridization
method were mainly evaluated. Moreover, these studies used
different DNA probes for either amplifications or translocations on
various tumor entities without adjusting the results to data
available from alternative cytogenetic approaches. Therefore, it
was of considerable interest to us to perform a comprehensive
study in order to meticulously assess the reliability of FISH analysis
in a high-throughput TMA setting not only for the widely used
break-apart probes, but especially also for the discovery of
deletions in FFPE tissue samples. Thus, we analyzed 46 B-NHL
samples with known karyotypes spotted on TMAs for hallmark
lymphoma-associated translocations of the IGH-, BCL2, BCL6-
and MYC-genes. FISH analysis was performed with a panel of
commercially available break-apart probes, and results were
compared also with data obtained from whole tissue sections of
corresponding samples. In summary, a total of 171/184 hybrid-
izations (94%) on the TMA format had appropriate hybridization
quality, enabling an accurate evaluation of FISH signals. This
result clearly indicates the excellent technical prerequisites in our
study, since comparable results had previously been published,
reporting a hybridization efficiency of more than 80% [3–5,9]. Of
those 171 hybridizations, 159 results (93%) were matching data
from classical chromosome banding. Of note, the FISH approach
was highly sensitive in the detection of translocations of BCL2,
BCL6, MYC and IGH, as well as of duplications and insertions
involving BCL6 within this study cohort. In addition, the
combined banding/interphase cytogenetic approach revealed 9/
171 (5%) alterations which were detected solely by FISH.
Considering these data, FISH analysis emerged as a very powerful
tool for the detection of translocations, in some conditions
exceeding the sensitivity of the chromosome banding approach,
in keeping with previous studies [10,11]. This of course holds
especially true in samples with a low or no yield of clonally
aberrant metaphases in the conventional cytogenetic workup, as
shown also in 5 of 9 tumor samples in our series (2 to 4 metaphases
analyzed, with only 2 to 3 clonal metaphases). In four cases
translocations were detected only by FISH. Similar data have been
emerged from previous studies indicating clonal heterogeneity and
the fact that selected tumor subclones might overgrow others in
vitro, thus resulting in an underestimation of subpopulations not
detectable with conventional banding approaches [11,12]. On the
other hand, in our study, chromosome banding turned out to be
superior to FISH analysis with regard to the detection of inversions
and deletions involving band 3q27/the BCL6 gene locus, which
obviously reflects the specificity of the BCL6 break-apart probe to
detect numerous translocations/aberrations in the alternate
breakpoint region (ABR) of the BCL6 gene, but not aberrations
occurring outside this region. Conventional chromosome banding
allows for a genome-wide screening of tumor-specific cytogenetic
aberrations within the order of resolution of the karyotype. FISH
analysis, in contrast, represents a highly sensitive and time-effective
alternative for the detection of targeted genetic alterations. Our
work especially points out the fact that targeted FISH is reliably
feasible in FFPE tissue TMA samples: results from TMA
hybridizations were fully reproducible when compared to whole
tissue section FISH of randomly assigned samples and in tumor
specimens showing discordant results of TMA-FISH and chro-
mosome banding. In a recent large study, in which cases from
different institutions had been assembled, hybridization efficiencies
ranging from 87% to 92% in the different TMAs were achieved,
thus proving the robustness of the assay. Moreover, highly
satisfactory kappa values of 0.92 to 0.94 were obtained in that
study when FISH results were evaluated between independent
observers in different institutions [9]. Finally, a round robin test
Figure 2. Comparison of FISH and qPCR in FL samples. Ten samples with detectable 6q-deletions as observed in chromosome banding
(positive controls) were investigated by FISH (A–C) and by qPCR (D). FISH was performed with 6q21- (red) (ATG5) and 6cen-specific (green) BAC-
clones. Representative overlay of Dapi-, SpectrumOrange (red: R) and SpectrumGreen (green: G) filters (A), either single SpectrumGreen (B) or
SpectrumOrange (C) filter indicating different signal constellations (wildtype: 2R2G; 6q21-deletion: 1R2G; section artefact: 1R1G) (magnification:
1006). Using the qPCR approach ten positive control samples were compared to five reactive lymph node specimens (D) (here referred to HBB as
internal control). For the qPCR approach, the cut-level obtained is indicated as dashed line. Although these samples clearly harboured deletions in the
chromosomal band 6q21 (including the ATG5-locus) as observed by FISH and chromosome banding, in only four of ten 6q-deleted FL samples loss of
the ATG5-gene was detected by qPCR.
doi:10.1371/journal.pone.0095047.g002
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recently conducted in Germany proved the high reproducibility of
FISH evaluation among different institutions [13]. These studies,
therefore, provide evidence for a high concordance rate of classical
cytogenetics and hybridizations of TMAs and whole tissue
sections. Only 13% of samples were not evaluable on the TMA
format due to inadequate pepsin digestion or loss of tissue cores
following pretreatment, and thus missing complete coverage of
adequate hybridization terms in all the different TMA-samples. A
dependence of hybridization efficiency also on the lymphoma
subtype has been recently shown [5].
While FISH analysis, in conclusion, clearly produces robust
results for the assessment of lymphoma-associated translocations,
the suitability of the FISH approach for the detection of deletions
of genetic material in FFPE tissue samples still is controversially
discussed [1,14]. In fact, some pitfalls do exist when searching for
copy number alterations in routine worked-up FFPE tissues. In
lymphomas, deletions are often representing secondary aberra-
tions that may not be present in the entire tumor cell population,
but only in tumor subclones. Moreover, the signal constellation
identified may often reflect the distribution of signals obtained
from truncated nuclei, when a part of the nucleus is lost following
sectioning of slides. An accurate establishment of the cut-off level
for the assessment of deletions, therefore, is highly recommended,
with adequate definition of negative controls [1,14]. In order to
address this question, we established an experimental set-up
allowing for the exact definition of the number of cells harboring
deletions in FFPE tissue, and performed a rigorous analysis
comparing FISH in TMA-format and on whole tissue sections
with both chromosome banding and qPCR in order to identify the
best-suited approach for the detection of numeric alterations in
FFPE tumor samples.
When analyzing serially diluted cell line samples containing
exactly defined numbers of cells with a given deletion, we were
able to determine a crucial threshold at a minimum of 25% of cells
containing the deletion, since 17% to 25% of cells turned out to
harbor truncated nuclei in every sample analyzed. In our study,
considering the number of up to 25% truncated nuclei identified in
an experimental setting on the one hand, and the calculated cut-
off ratio of 30% on the other hand, only samples harboring
deletion-like signal constellations in $30% of cells were designated
as positive. Similar high cut-off ratios ranging between 20% to
41% have also been proposed in previous publications [14,15].
These studies, however, had been performed on whole tissue
sections only. Thus, to the best of our knowledge, the present study
is the first to assess the robustness of detecting deletions in FFPE
tissue samples spotted on TMAs. Losses of genetic material
detected by FISH analysis in the present study occurred in 32% to
75% of cells in mesothelioma samples (mean: 52%) and in 38% to
70% of cells in FL samples (mean: 52%). The large range of results
in FL most probably reflects the different composition of the
cellular microenvironment in these lymphomas, with largely
varying numbers of non-tumorous bystander cells in different
samples. Interestingly, qPCR could validate the FISH results only
in samples with biallelic deletions and in specimens with
monoallelic deletions, but a high tumor cell content, although
the qPCR approach had been successfully established in an
experimental model set up. There are several explanations to
explain the inferiority of qPCR when compared with FISH in the
FFPE tumor samples. Successful PCR analysis requires DNA of
adequate quality, which is often limited when working-up FFPE
specimens [16]. Moreover, when investigating tumor samples,
underlying genetic alterations generally have to be considered,
possibly also affecting the loci of reference genes used. In our
study, for example, we could not exclude that reference loci
harbored copy number changes and thus, influenced the
measurement of the target genetic region. This caveat obviously
turned up in three MM tumor sample, that was deletion-positive
when referred to HBB, but not to MAL as internal control.
In conclusion, FISH represented an excellent tool for the
detection of structural as well as numerical aberrations in FFPE
tissue samples in a TMA-based high-throughput setting in an
experimental study. It should be kept in mind, however, that
secondary genetic lesions might not be representative for the whole
tumor population. Therefore, the application of rigorous cut-off
values and the usage of appropriate controls is required. When
carefully considering these aspects, FISH is a highly reliable and
reproducible method allowing for the rapid detection of deletions
on TMAs the sensitivity of which obviously exceeds that of a
qPCR approach.
Materials and Methods
Tumor Specimens
Archival FFPE tissue blocks of 46 B-NHL (all with chromosome
banding data available) were punched and arranged on a TMA
format. Of these specimens, 24 were primary nodal diffuse large B-
cell lymphomas (DLBCL), 11 extranodal DLBCL, and 11
follicular lymphomas (FL). Whole tissue sections for FISH analysis
were cut from 25 of these cases. Numerical genetic alterations
were analyzed in 62 follicular lymphoma (FL) (10 of 62 with
cytogenetic data) and six mesothelioma specimens (without
cytogenetic data) that had also been spotted on TMAs. All
paraffin blocks were retrieved from the files of the Institute of
Pathology, University of Wu¨rzburg, Germany and from the
Department of Clinical Pathology, Robert-Bosch-Krankenhaus,
Stuttgart, Germany. Chromosome banding analyses had been
generated as a part of the diagnostic work-up for the 46 B-NHL
tumor samples from 1993 to 2007 at the Institute of Pathology,
University of Wu¨rzburg, Germany. All cases were reviewed and
classified according to the criteria of the current World Health
Organization (WHO) classification systems [17,18]. The study was
approved by the local Ethics committees, that also waived the need
for written informed consent from the donor (Ethics committee of
the Medical Faculty, Eberhard-Karls-University and University
Hospital Tu¨bingen and Ethics committee of the Medical Faculty,
University of Wu¨rzburg), in accordance with the Declaration of
Helsinki.
Cell Lines
To obtain insight into the reliability of testing numerical genetic
alterations (especially deletions) in FFPE tissues, mantle cell
lymphoma cell lines REC1 and JVM2 (DSMZ, Braunschweig,
Germany) were utilized. These cell lines are well-characterized on
the genetic level [19]. With special regard to the 9p21 locus, REC1
was shown to harbor a homozygous deletion of CDKN2A, while
JVM2 retains two copies of CDKN2A [19]. Cell lines were cultured
in RPMI-1640 medium (Life Technologies, Darmstadt, Ger-
many), supplemented with 10% heat inactivated fetal bovine
serum, 50 mg/ml streptomycin and penicillin (Life Technologies)
and maintained in a humidified 95% air – 5% CO2 atmosphere at
37uC. In an experimental setting, REC1 cells were serially spiked
into JVM2 cell suspensions to obtain suspensions with a defined
content of CDKN2A-deleted cells (0%, 25%, 50%, 75%, 100% cells
with deletion of CDKN2A). For comparison with the routine
setting, 46106 cells of the cellular suspensions were washed with
100% isopropanol, fixed with buffered formalin and embedded
into paraffin. Subsequent FISH analyses were performed on whole
tissue sections.
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TMA construction
Tumor areas of paraffin tissue blocks were screened paying
attention to the content of viable, well-fixed tissue. Three 0.6 mm
thick cores were taken from the selected regions of the donor block
with a ‘manual tissue puncher’ (Beecher Instruments, Silver
Spring, Maryland, USA) and inserted into the recipient block. A
total of four TMAs were constructed containing the 46 B-NHL
(two TMAs with 20 and 26 samples, respectively) and the 62 FL
together with six MM tumor samples (two TMAs with 34 samples,
respectively).
Chromosome banding
Metaphases had been prepared from short-term cell cultures of
the 46 B-NHL cases according to standard protocols [20]. After
classical Giemsa-trypsin banding, karyotypes were constructed
according to the International System for Human Cytogenetic
Nomenclature (ISCN). Identical structural aberrations, or genetic
gains, in two or more metaphases and identical genetic losses in at
least three metaphases were defined as clonal aberrations.
FISH
Interphase-FISH was performed on 4 mm thick tissue sections.
Hybridization was performed as previously described [9]. Briefly,
whole tissue and TMA sections were deparaffinized, re-hydrated
in 100, 80 and 70% ethanol, followed by incubation in 50 mM
Tris-EDTA (pH 8.0) for 10 min at 100uC. The slides were then
treated with pepsin (62.5 mg/ml in 0.01 N HCl) at varying times at
37uC, followed by dehydration in 70, 80 and 100% ethanol and
denaturation for 10 min at 80uC. The slides were hybridized with
125 ng SO- and SG-labeled BAC-DNA probes, respectively, or
following the manufacturers protocol for Vysis BCL2-, Vysis IGH-
and Vysis MYC Break Apart FISH Probe Kits, and Vysis LSI
BCL6 (ABR) Dual Color, Break Apart Rearrangement Probe
(Abbott Molecular, Wiesbaden-Delkenheim, Germany). After
overnight hybridization at 37uC in a humid chamber, slides were
washed and counterstained with 1.5 mg/ml DAPI in mounting
medium (Axxora, Lo¨rrach, Germany). In an initial test set, a TMA
section covering 20 FL was treated with pepsin with varying
incubation times (4 to 10 minutes) and hybridized with break-
apart probes for the BCL2- and the IGH-gene loci (40 hybridiza-
tion events). Hybridization efficiency was highest with 6 min
pepsin digestion time yielding 80% to 94% samples with good
hybridization results. This pretreatment condition was then
applied to all subsequent FISH analyses. For the detection of
chromosomal deletions involving CDKN2A in chromosome 9p21
the Vysis CDKN2A/CEP 9 FISH Probe Kit (Abbott Molecular)
was used. Chromosomal deletions affecting 6q21 were analyzed
applying the locus-specific bacterial artificial chromosome (BAC)
probe RP11-106L23 (ATG5) (NCBI-ID: 206657, NC_000006.11,
http://www.ncbi.nlm.nih.gov/clone/), in co-analysis with the
chromosome 6 centromeric probe RP11-79O24 (NCBI-ID:
255610, NC_000006.11) (Source BioScience LifeSciences, Berlin,
Germany), as previously described [21].
Tissue sections from three FFPE reactive lymph nodes had been
used to determine the cut-off level for each probe. The reference
range (cut-off) was defined as the mean copy number in lymph
nodes plus three standard deviations. The cut-off levels were 10%
(95% CI: 6.9–9.8), 8% (95% CI: 4.9–7.8), 9% (95% CI: 6.2–9.1)
and 9% (95% CI: 5.9–8.8) for rearrangements of the BCL2-, BCL6,
IGH- and MYC gene probes, respectively. For the deletion probes,
the cut-off levels were set at 30% each for CDKN2A (calculated cut-
off: 29%; 95% CI: 13.1–28.2) and ATG5 (calculated cut-off: 28%;
95% CI: 12.1–27.2), respectively. Sections from three FFPE FL
samples with known deletions in 6q by chromosome banding were
used as positive controls. At least 100 intact nuclei per case were
evaluated using an epifluorescence microscope (Leica Microsys-
tems, Bensheim, Germany). Images were captured using the ISIS
imaging system (MetaSystems, Altlussheim, Germany). For
accurate evaluation of the results, two independent observers
scored the signal constellation in 100 nuclei of two cores. The third
core, as a rule, was evaluated only qualitatively to ensure equal
signal distribution in all cores of one sample. In none of the
samples discordant evaluation results were obtained for the three
individual cores of one B-NHL case.
Real-time quantitative PCR
To detect genomic deletions quantitative real-time PCR (qPCR)
was performed as previously described [22]. Genomic DNA was
extracted from 10 mm FFPE sections using the QIAamp DNA
FFPE Tissue Kit (Qiagen, Hilden, Germany) according to the
manufacturers protocol.
Primers for qPCR targeting CDKN2A (9p21) and ATG5 (6q21)
were designed based on published sequence data (NG_007485.1,
NC_000006): CDKN2A_sense 59-GATCCTTGTTAGCATTT-
CAG-39; CDKN2A_antisense 59-AGAGTGGAGGACCCGTG-
39; ATG5_sense 59-AAGGGCCAACTGTGTACGTC-39; AT-
G5_antisense 59-CCATCTCTTGGCATTCCCTA-39. As refer-
ence loci, HBB (11p15), TMEM2 (9q21) and MAL (2q11) were
selected based on the results of SNP-array and comparative
genomic hybridization studies that had shown only infrequent
genetic aberrations in these regions in B-NHL as well as in
malignant mesothelioma [6,23]. Previously described primers for
HBB were applied [21]. Primers for TMEM2 and MAL
amplification were TMEM2_sense 59-GCTTACAGGGTGG-
TGTTC-39; TMEM2_antisense 59-GGATCAGGATGTAAT-
GAGTC-39; MAL_sense 59-TAATTGGAGCCCACGGTG-39;
MAL_antisense 59-AGCGGTGCAGTGGTAGG-39. Loss of
chromosomal material was calculated by normalizing ATG5 and
CDKN2A qPCR data to the reference loci. The cut-off value for
deletion was defined as the mean value in four to six reactive
lymph nodes (FFPE) minus three standard deviations. The cut-off
ratios for ATG5/TMEM2 and ATG5/HBB were 0.47 and
0.46, respectively. For CDKN2A/TMEM2, CDKN2A/HBB and
CDKN2A/MAL cut-off ratios of 0.54, 0.52 and 0.50 were
calculated, respectively. Genomic DNA extracted from three FL
FFPE samples that showed deletions of the 6q-region by
chromosome banding were used as positive controls. Genomic
DNA of REC1 cells, that harbor a homozygous deletion of
CDKN2A was used as positive control for the detection of losses in
9p21.
Supporting Information
Table S1 Detailed results of all experiments performed
within the entire study cohort consisting of DLBCL, FL
and MM specimens. The numbers of cases studied and the
individual in samples with chromosome banding data available,
the FISH-probes used for the detection of either structural or
numerical genomic aberrations, the number of cases investigated
by either TMA-FISH or FISH of whole tissue sections and the
number of cases additionally analyzed by qPCR are given. FISH
results are provided as numbers of positive cells in [%], if aberrant,
while qPCR results indicating genetic deletion are provided as
‘loss’. Abbrevations: DLBCL: Diffuse large B-cell lymphoma; FL:
Follicular lymphoma; BAP: Break-apart probe; LSI: locus-specific
identifier; Chr.: chromosome; WTS: whole tissue section; qPCR:
quantitative real-time PCR on the DNA-level; Karyotypic
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abbreviations: der: derivative; del: deleted; bidel: biallelic deletion;
dup: duplicated; add: added.
(XLSX)
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